Dogwood Therapeutics, Inc DWTX
1.36
(0.07)
(4.90%)
as of 25 Sep
- Market cap
- $48.6M
- P/E
- 0.0×
Follow DWTX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
2.76 | 5.21 | 11.62 | 8.02 | 12.37 | 20.55 | 0.19 | 0.03 | — |
Net Debt/EBITDA |
0.23 | (0.04) | 0.61 | 0.57 | 0.90 | 2.99 | (1.57) | 0.02 | — |
Debt/Assets |
0.00% | 16.31% | 0.00% | 0.00% | 0.00% | 0.00% | 1,151.47% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | (0.72) | 0.00 | — |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.44 | 0.68 | 0.92 | 0.94 | 0.98 | 0.38 | 0.85 | 0.60 | — |
Capex/Depreciation |
0.00 | 0.00 | — | — | — | 0.00 | 0.00 | — | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| (109.66%) | 407.25% | (95.14%) | (112.22%) | (71.83%) | (83.03%) | 24.54% | 12.90% | — | |
| (38.50%) | (26.13%) | (84.50%) | (101.45%) | (67.56%) | (65.10%) | (1,295.76%) | (6,414.57%) | — | |
ROIC |
(25.57%) | (11.79%) | (694.76%) | (2,604.76%) | (1,983.28%) | (4,297.85%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
(659.52%) | (96.11%) | (139.12%) | (167.17%) | (110.06%) | (34.56%) | 189.55% | 164.62% | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Intangible Assets out of Total Assets |
0.90 | 0.82 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — | — |
Free Cash Flow per Share |
(3.14) | (8.55) | (6.49) | (25.90) | (47.09) | (19.76) | (10.82) | (0.15) | — |
Cash per Share |
1.31 | 14.44 | 4.42 | 15.88 | 42.04 | 151.17 | 1.60 | 0.00 | — |
Shareholders Equity per Share |
15.05 | 62.53 | 5.07 | 16.55 | 43.52 | 151.91 | (25.96) | (1.83) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
15.05 | 62.53 | 5.07 | 16.55 | 43.52 | 151.91 | (25.96) | (1.83) | — |
Free Cash Flow |
(15.62) | (8.79) | (4.87) | (11.47) | (15.69) | (3.90) | (2.09) | (1.27) | — |
Working Capital |
5.37 | 13.37 | 3.81 | 7.33 | 14.50 | 29.94 | (1.30) | (1.28) | — |
Net Current Asset Value |
(6.84) | (13.48) | 3.81 | 7.33 | 14.50 | 29.94 | (5.02) | (1.28) | — |
| Other line items | |||||||||
Quick Ratio |
2.13 | 4.67 | 9.25 | 6.74 | 10.98 | 19.45 | 0.19 | 0.02 | — |
Depreciation/Fixed assets |
4.25 | 4.20 | — | — | — | 0.00 | 0.00 | — | — |
Cash ROIC |
(19.20%) | (9.32%) | (68.37%) | (79.87%) | (55.03%) | (6.52%) | 195.42% | 8.37% | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF per Share |
(3.14) | (8.55) | (6.49) | (25.90) | (47.09) | (19.76) | (10.82) | (0.15) | — |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Payables |
1.00 | 0.67 | 0.34 | 0.46 | 0.36 | 0.20 | 0.09 | 0.09 | — |
Average Assets |
92.24 | 49.24 | 6.27 | 12.07 | 23.62 | 15.89 | 0.19 | 0.03 | — |
Average Common Equity |
32.39 | (3.16) | 5.57 | 10.91 | 22.22 | 12.46 | (10.08) | (16.38) | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Columns are period end dates